###begin article-title 0
###xml 76 88 76 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 88 100 88 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pseudomallei</italic>
Toll-Like Receptor 2 Impairs Host Defense in Gram-Negative Sepsis Caused by Burkholderiapseudomallei (Melioidosis)
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 350 376 350 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia pseudomallei,</italic>
###xml 350 375 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Toll-like receptors (TLRs) are essential in host defense against pathogens by virtue of their capacity to detect microbes and initiate the immune response. TLR2 is seen as the most important receptor for gram-positive bacteria, while TLR4 is regarded as the gram-negative TLR. Melioidosis is a severe infection caused by the gram-negative bacterium, Burkholderia pseudomallei, that is endemic in Southeast Asia. We aimed to characterize the expression and function of TLRs in septic melioidosis.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 176 204 176 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14, TLR1, TLR2, TLR4, LY96</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MD-2</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR5,</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 461 476 461 476 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 672 687 672 687 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 20 28 <span type="species:ncbi:9606">patients</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 461 476 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 672 687 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 731 736 <span type="species:ncbi:10090">Mouse</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
Patient studies: 34 patients with melioidosis demonstrated increased expression of CD14, TLR1, TLR2, and TLR4 on the cell surfaces of monocytes and granulocytes, and increased CD14, TLR1, TLR2, TLR4, LY96 (also known as MD-2), TLR5, and TLR10 mRNA levels in purified monocytes and granulocytes when compared with healthy controls. In vitro experiments: Whole-blood and alveolar macrophages obtained from TLR2 and TLR4 knockout (KO) mice were less responsive to B. pseudomallei in vitro, whereas in the reverse experiment, transfection of HEK293 cells with either TLR2 or TLR4 rendered these cells responsive to this bacterium. In addition, the lipopolysaccharide (LPS) of B. pseudomallei signals through TLR2 and not through TLR4. Mouse studies: Surprisingly, TLR4 KO mice were indistinguishable from wild-type mice with respect to bacterial outgrowth and survival in experimentally induced melioidosis. In contrast, TLR2 KO mice displayed a markedly improved host defenses as reflected by a strong survival advantage together with decreased bacterial loads, reduced lung inflammation, and less distant-organ injury.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 187 202 187 202 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 237 253 237 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei,</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 187 202 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 237 252 <span type="species:ncbi:28450">B. pseudomallei</span>
Patients with melioidosis displayed an up-regulation of multiple TLRs in peripheral blood monocytes and granulocytes. Although both TLR2 and TLR4 contribute to cellular responsiveness to B. pseudomallei in vitro, TLR2 detects the LPS of B. pseudomallei, and only TLR2 impacts on the immune response of the intact host in vivo. Inhibition of TLR2 may be a novel treatment strategy in melioidosis.
###end p 6
###begin p 7
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
Willem Wiersinga and colleagues find up-regulation of multiple Toll-like receptors (TLRs) in peripheral blood cells of patients with melioidosis. However, only TLR2 had an effect on the immune response in a mouse model.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 67 92 67 92 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 563 578 563 578 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 67 92 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 495 501 <span type="species:ncbi:9606">people</span>
###xml 563 578 <span type="species:ncbi:28450">B. pseudomallei</span>
Melioidosis is a severe tropical infection caused by the bacterium Burkholderia pseudomallei. This soil-dwelling pathogen (disease-causing organism) enters the body through cuts, by swallowed contaminated water, or by inhaled contaminated dust. Here, it can cause a severe lung infection or spread into the blood stream and around the body, where it causes widespread inflammation (sepsis) and organ failure. Untreated septic melioidosis is usually fatal. Even with antibiotic therapy, half the people who develop it in Thailand (a hot spot for melioidosis) die. B. pseudomallei is a "gram-negative" bacterium. That is, it is surrounded by a membrane that stops it taking up a stain used to detect bacteria. This membrane contains a molecule called lipopolysaccharide (LPS). Proteins on immune system cells called Toll-like receptors (TLRs), of which there are many, recognize LPS and other surface molecules common to different pathogens and tell the cells to make cytokines. These cytokines stimulate the immune system to kill the pathogen but also cause inflammation, the underlying problem in septic melioidosis and other forms of sepsis. In other words, TLRs are two-edged swords-they provide an essential first-line defense against pathogens, but cause life-threatening inflammation if overstimulated.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 101 116 101 116 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 183 198 183 198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 465 480 465 480 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 101 116 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 183 198 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 465 480 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
It isn't known which TLRs are involved in melioidosis. TLR4 normally detects LPS, but the surface of B. pseudomallei also carries molecules that interact with TLR2. Understanding how B. pseudomallei interacts with TLRs might suggest new, more effective ways to treat septic melioidosis. Better remedies for this disease are badly needed because, as well as the infections it causes in the community, the US Centers for Disease Control and Prevention has identified B. pseudomallei as a potential bioterrorism agent. In this study, the researchers have characterized the expression and function of TLRs in septic melioidosis using human, in vitro (test tube), and animal approaches.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 450 465 450 465 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 964 979 956 971 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1055 1070 1047 1062 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1228 1243 1220 1235 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 172 178 <span type="species:ncbi:9606">people</span>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 450 465 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 802 807 <span type="species:ncbi:9606">human</span>
###xml 964 979 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1008 1013 <span type="species:ncbi:9606">human</span>
###xml 1055 1070 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1228 1243 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
The researchers isolated monocytes and granulocytes (immune system cells involved in first-line defenses against pathogens) from patients with melioidosis and from healthy people. The patients' cells made more TLR1, TLR2, TLR4, and CD14 (a protein that enhances the activation of immune system cells by LPS) than those of the healthy controls and more of the mRNAs encoding several other TLRs. Next, the researchers tested the ability of heat-killed B. pseudomallei to induce the release of TNFalpha (a cytokine produced in response to TLR signaling) from macrophages (immune system cells that swallow up pathogens) isolated from wild-type mice and from mice lacking TLR2 or TLR4. Macrophages isolated from wild-type mice made more TNFalpha than those from TLR2- or TLR4-deficient mice. In addition, a human kidney cell line engineered to express CD14/TLR2 or CD14/TLR4 but not the parent cell line released IL8 (another cytokine) when stimulated with heat-killed B. pseudomallei. Other experiments in these human cell lines showed that LPS purified from B. pseudomallei signals through TLR2 but not through TLR4. Finally, the researchers tested the ability of TLR2- and TLR4-deficient mice to survive after infection with live B. pseudomallei. Compared with TLR4-deficient or wild-type mice, the TLR2-deficient mice had a strong survival advantage, a lower bacterial load, reduced lung inflammation, and less organ damage.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 148 163 148 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 282 297 282 297 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 483 498 483 498 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 566 581 566 581 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 669 684 669 684 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 25 31 <span type="species:ncbi:9606">people</span>
###xml 148 163 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 282 297 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 483 498 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 566 581 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 669 684 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 759 765 <span type="species:ncbi:9606">people</span>
###xml 870 876 <span type="species:ncbi:9606">people</span>
These findings show that people with melioidosis have increased expression of several TLRs, any one of which might cause the sepsis associated with B. pseudomallei infection. The in vitro findings indicate that TLR2 and TLR4 both contribute to the responsiveness of immune cells to B. pseudomallei in test tubes, but that only TLR2 detects the LPS of this bacterium. This unexpected result-TLR4 normally responds to LPS-might indicate that there is something unique about the LPS of B. pseudomallei. Finally, the survival of TLR2-deficient mice after infection with B. pseudomallei suggests that TLR2-mediated dysregulation of the immune system in response to invasive B. pseudomallei might cause septic melioidosis. Although these results need confirming in people, they suggest that inhibition of TLR2 in combination with antibiotic therapy might improve outcomes for people with melioidosis.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
Information is available from the US Centers for Disease Control and Prevention on  (in English and Spanish)
###end p 19
###begin p 20
The UK Health Protection Agency provides information for the public and health professionals on 
###end p 20
###begin p 21
Wikipedia has pages on  and on  (note: Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)
###end p 21
###begin p 22
The MedlinePlus encyclopedia contains a page on  (in English and Spanish)
###end p 22
###begin title 23
Introduction
###end title 23
###begin p 24
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b001">1</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b002">2</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b001">1</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b002">2</xref>
###xml 628 633 <span type="species:ncbi:9606">human</span>
The recently discovered family of Toll-like receptors (TLRs), which are conserved across many species, has emerged as an important first line of defense against invading pathogens. They detect host invasion by pathogens, initiate immune responses, and form the crucial link between the innate and adaptive immune systems [1,2]. Upon the first encounter with a pathogen, TLRs recognize conserved motifs termed pathogen-associated molecular patterns (PAMPs) [1,2]. In general, the immune activation that follows the interaction between TLRs and PAMPs is sufficient to eliminate the wide variety of pathogens that daily invade the human body. However, in the case of sepsis, these TLR-mediated inflammatory responses may exceed the threshold below which immune system homeostasis is maintained and thereby cause harm.
###end p 24
###begin p 25
###xml 82 107 82 107 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b003">3</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b004">4</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b005">5</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b006">6</xref>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b007">7</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b003">3</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b008">8</xref>
###xml 729 744 729 744 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 82 107 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 729 744 <span type="species:ncbi:28450">B. pseudomallei</span>
In Southeast Asia and northern Australia the gram-negative soil-dwelling bacillus Burkholderia pseudomallei is an important cause of community-acquired sepsis and sepsis-related mortality [3,4]. More than half of the cases of melioidosis, as this severe infection is named, commonly presents with pneumonia with bacterial dissemination to distant sites [5]. The mortality of primary disease is 50% in northeast Thailand and around 20% in the higher-technology setting of northern Australia [6,7]. Reported cases are likely to represent "the tip of the iceberg," since confirmation of disease depends on bacterial isolation, a technique that is not available in large areas of the world [3,8]. Interest in disease pathogenesis of B. pseudomallei has increased following its classification as a category B disease/agent of bioterrorism by the US Centers for Disease Control and Prevention ().
###end p 25
###begin p 26
###xml 58 74 58 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei.</italic>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b009">9</xref>
###xml 408 424 408 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei,</italic>
###xml 58 73 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 408 423 <span type="species:ncbi:28450">B. pseudomallei</span>
It is likely that TLRs contribute to host defense against B. pseudomallei. In general, TLR4 is considered of utmost importance for host defense against gram-negative infection by virtue of its capacity to sense lipopolysaccharide (LPS) present in the outer membrane of gram-negative bacteria and to relay LPS effects into the cellular interior [9]. Besides TLR4, TLR2 may play a role in the host response to B. pseudomallei, given that this bacterium expresses several PAMPs that can interact with TLR2, including lipopeptides and peptidoglycan. However, these assumptions remain speculative since the expression and function of these TLRs have not been studied in melioidosis thus far.
###end p 26
###begin p 27
###xml 102 117 102 117 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 203 218 203 218 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 102 117 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 203 218 <span type="species:ncbi:28450">B. pseudomallei</span>
In the present study we aimed to characterize the expression and function of TLRs in sepsis caused by B. pseudomallei and found that, although both TLR2 and TLR4 contribute to cellular responsiveness to B. pseudomallei in vitro, only TLR2 impacts on the immune response of the intact host in vivo.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Studies
###end title 29
###begin title 30
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients.
###end title 30
###begin p 31
###xml 64 79 64 79 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 361 376 361 376 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 629 631 609 611 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">co</sc>
###xml 631 632 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 753 754 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 770 771 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 834 836 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b010">10</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 64 79 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 81 89 <span type="species:ncbi:9606">Patients</span>
###xml 361 376 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 980 983 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1117 1125 <span type="species:ncbi:9606">patients</span>
###xml 1534 1546 <span type="species:ncbi:9606">participants</span>
Blood samples were taken from 34 patients with sepsis caused by B. pseudomallei. Patients were prospectively recruited over a 4 mo period after admission to Sapprasithiprasong Hospital, a 1,000-bed government hospital located in Ubon Ratchathani, northeast Thailand. Sepsis caused by melioidosis was defined by the presence of (1) culture-proven infection with B. pseudomallei and (2) systemic inflammatory response syndrome (SIRS) as indicated by three or more of the following criteria: a core temperature of >/= 38 degreesC or </= 36 degreesC; a heart rate of >/= 90 beats/min; a respiratory rate of >/= 20 breaths/min or a Paco2 of >/= 32 mm Hg or the use of mechanical ventilation for an acute respiratory process; a white-cell count of >/= 12 x 109/l or </= 4 x 109/l or a differential count showing > 10% immature neutrophils [10]. Exclusion criteria were the use of dialysis and/or immunosuppressive therapy, known disorders of coagulation, and concomitant infection with HIV. Blood samples were drawn within 36 h after start of antimicrobial therapy. When possible, an additional blood sample was drawn from patients who recovered after 2 wk of treatment. 32 healthy individuals, who were recruited from the Sapprasithiprasong Hospital blood bank as blood donors, served as a control population. The study was approved by both the Ministry of Public Health, Royal Government of Thailand and the Oxford Tropical Research Ethics Committee, University of Oxford, England and written informed consent was obtained from all study participants or their attending relatives.
###end p 31
###begin title 32
RNA analysis using multiplex ligation-dependent probe amplification.
###end title 32
###begin p 33
###xml 611 613 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b011">11</xref>
###xml 614 616 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b014">14</xref>
###xml 1146 1148 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b015">15</xref>
###xml 1327 1353 1321 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">beta-2 microglobulin (B2M)</italic>
###xml 1431 1433 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b011">11</xref>
###xml 1434 1436 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b014">14</xref>
Heparinized blood samples were drawn from the antecubital vein and immediately put on ice. Leukocytes were isolated using erythrocyte lysis buffer. Monocyte- and granulocyte-enriched populations were isolated using Polymorphprep (Axis-Shield, ). Monocyte and granulocyte fractions were > 98% pure as determined by their scatter pattern on flow cytometry. After isolation leukocytes, monocytes, and granulocytes were dissolved in Trizol (Invitrogen, ) and stored at -80 degreesC until used for RNA isolation. RNA was isolated and analyzed by multiplex ligation-dependent probe amplification (MLPA) as described [11-14] using a TLR-specific kit developed in collaboration with MRC-Holland () for the simultaneous detection of 17 mRNA molecules; four different probe sets were generated for TLR4 corresponding with four different TLR4 splice variants (R01 to R04) identified in the National Center for Biotechnology Information (NCBI) (); similarly, two different probe sets for TLR8 were generated corresponding with two different TLR8 splice variants (R01 and R02). We recently published the specific oligonucleotides used for all TLR probe sets [15]. All samples were tested with the same batch of reagents. The levels of mRNA for each gene were expressed as a normalized ratio of the peak area divided by the peak area of the beta-2 microglobulin (B2M) gene, resulting in the relative abundance of mRNAs of the genes of interest [11-14].
###end p 33
###begin title 34
FACS analysis.
###end title 34
###begin p 35
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
CD14 and TLR cell surface expression on peripheral monocytes and granulocytes was determined by flow cytometry using fluorochrome-conjugated mouse anti-human CD14 (BD Biosciences, ), TLR1, TLR2, and TLR4 (all eBioscience, ) antibodies in accordance with the manufacturer's recommendations. Granulocytes were defined according to their scatter pattern and monocytes according to their scatter pattern and CD14 positivity. To correct for nonspecific staining, appropriate isotype control antibodies (BD Biosciences) were used. Samples were analyzed directly after sample collection by flow cytometry using FACScan (BD Biosciences).
###end p 35
###begin title 36
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse and In Vitro Studies
###end title 36
###begin title 37
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 37
###begin p 38
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b016">16</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b017">17</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
Pathogen-free 8- to 10-wk-old wild-type (WT) C57BL/6 mice were purchased from Harlan Sprague Dawley (). TLR2 knockout (KO) mice [16] and TLR4 KO mice [17] backcrossed six times to a C57BL/6 background were generously provided by Dr. Shizuo Akira, Osaka University, Japan. Age- and sex-matched animals were used in all experiments. The Animal Care and Use of Committee of the University of Amsterdam approved all experiments.
###end p 38
###begin title 39
Preparation of alveolar macrophages.
###end title 39
###begin p 40
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b018">18</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b019">19</xref>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 863 878 862 877 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 911 913 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b020">20</xref>
###xml 914 916 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b021">21</xref>
###xml 925 926 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 863 878 <span type="species:ncbi:28450">B. pseudomallei</span>
Alveolar macrophages were harvested from TLR2 KO, TLR4 KO, and WT mice by bronchoalveolar lavage (n = 5-8 per strain) as described [18,19].The trachea was exposed through a midline incision and cannulated with a sterile 22-gauge Abbocath-T catheter (Abbott, ). Bronchoalveolar lavage was performed by instilling three 0.5 ml aliquots of sterile saline. Total cell numbers were counted from each sample using a hemacytometer. Cells were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM L-glutamine, penicillin/ streptomycin (100 units penicillin, 100 g streptomycin), and 10% FCS in a final concentration of 1 x 104 cells/100 mul. Cells were then cultured in 96-well microtiter plates (Greiner, ) for 2 h and washed with RPMI 1640 to remove nonadherent cells. Adherent monolayer cells were stimulated with washed (three times in normal saline), heat-killed B. pseudomallei (clinical isolate strain 1026b [20,21]; 1 x 105 colony-forming units (CFU)/ml) or RPMI 1640 for 16 h. Supernatants were collected and stored at -20 degreesC until assayed for tumor necrosis factor alpha (TNFalpha).
###end p 40
###begin title 41
###xml 20 35 20 35 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 20 35 <span type="species:ncbi:28450">B. pseudomallei</span>
LPS extraction from B. pseudomallei 1026.
###end title 41
###begin p 42
###xml 23 38 23 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b022">22</xref>
###xml 513 515 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b023">23</xref>
###xml 527 542 515 530 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 598 600 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b024">24</xref>
###xml 23 38 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 527 542 <span type="species:ncbi:28450">B. pseudomallei</span>
LPS was extracted from B. pseudomallei 1026b [22]. Bacteria from frozen stock were inoculated into 5 ml of LB broth and incubated overnight at 37 degreesC in air with shaking at 200 rpm. This starting culture was streaked onto 50 LB agar plates per strain. Plates were incubated at 37 degreesC in air for 2 d, after which bacterial colonies were scraped from plates and resuspended in 100 ml of sterile distilled water. LPS extraction using a hot aqueous-phenol method was performed as described by Brett et al. [23]. Purified B. pseudomallei LPS was characterized by SDS-PAGE and silver staining [24].
###end p 42
###begin title 43
HEK cells.
###end title 43
###begin p 44
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b025">25</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b026">26</xref>
###xml 265 280 265 280 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 312 327 312 327 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 265 280 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 312 327 <span type="species:ncbi:28450">B. pseudomallei</span>
Human embryonic kidney (HEK) 293 cells stably expressing CD14, CD14-TLR4, or CD14-TLR2, kindly provided by Dr. Douglas Golenbock, University of Massachusetts Medical School, Worcester, Massachusetts, have been described [25,26]. Cells were stimulated with LPS from B. pseudomallei 1026b (100 ng/ml), heat-killed B. pseudomallei (5 x 107 CFU/ml), or RPMI for 6 h. Supernatants were harvested and stored at -20 degreesC until assayed for interleukin (IL) 8.
###end p 44
###begin title 45
Experimental infection.
###end title 45
###begin p 46
###xml 33 48 33 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b020">20</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b021">21</xref>
###xml 424 425 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 607 608 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 700 701 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 860 861 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 33 48 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 186 190 <span type="species:ncbi:4530">rice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
For preparation of the inoculum, B. pseudomallei strain 1026b was used (this strain was isolated in Sappasithiprasong Hospital in 1993 from a blood culture from a septic 29-y-old female rice farmer, who presented with bacteremia with soft tissue, skin, joint, and spleen involvement [20,21]). Stock bacteria were streaked from frozen aliquots into 50 ml Luria broth (Difco) for overnight incubation at 37 degreesC in a 5% CO2 incubator. Thereafter, a 1 ml portion was transferred to fresh Luria broth and grown for approximately 5 h to midlogarithmic phase. Bacteria were harvested by centrifugation at 1500g for 15 min, washed, and resuspended in sterile isotonic saline at a concentration of 5 x 102 CFU/50 mul, as determined by plating serial 10-fold dilutions on blood agar plates. Pneumonia was induced by intranasally inoculating mice with 50 mul (5 x 102 CFU) of bacterial suspension. For this procedure, mice were lightly anesthetized by inhalation of isofluorane (Upjohn).
###end p 46
###begin title 47
Determination of bacterial outgrowth.
###end title 47
###begin p 48
###xml 522 523 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
At 24, 48, and 72 h after infection, mice were anesthetized with Hypnorm (Janssen Pharmaceutica, ; active ingredients, fentanyl citrate and fluanisone) and midazolam (Roche, ) and sacrificed by bleeding from the inferior vena cava. The lungs and spleens were harvested and homogenized at 4 degreesC in four volumes of sterile saline using a tissue homogenizer (Biospec Products, ). CFUs were determined from serial dilutions of organ homogenates and blood, plated on blood agar plates and incubated at 37 degreesC at 5% CO2 for 16 h before colonies were counted.
###end p 48
###begin title 49
Preparation of lung tissue for cytokine measurements.
###end title 49
###begin p 50
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 145 143 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sub>
###xml 297 298 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
For cytokine measurements, lung homogenates were diluted 1:2 in lysis buffer containing 300 mM NaCl, 30 mM Tris (pH 7.4), 2 mM MgCl2, 2 mM CaCl2, 1% Triton X-100, and pepstatin A, leupeptin, and aprotinin (all 20 ng/ml) and incubated at 4 degreesC for 30 min. Homogenates were centrifuged at 1,500g at 4 degreesC for 15 min, and supernatants were stored at -20 degreesC until assays were performed.
###end p 50
###begin title 51
Assays.
###end title 51
###begin p 52
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 52 <span type="species:ncbi:10090">Mouse</span>
Human IL8 was measured by ELISA (Biosource, ). Mouse TNFalpha, IL6, and IL10 were measured by cytometric bead array multiplex assay (BD Biosciences) in accordance with the manufacturer's recommendations. Aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) were determined with commercially available kits (Sigma-Aldrich, ), using a Hitachi analyzer (Roche) according to the manufacturer's instructions. Immunostaining for TLR4 on blood cells and whole lung-cell suspensions was performed using directly labeled antibodies against GR-1 (GR-1 FITC; Pharmingen) and TLR4 (TLR4-AlexaFluor, all Bioscience) and a biotin-labeled antibody against F4/80 (Serotec, ) in combination with streptavidin allophycocyanine. All antibodies were used in concentrations recommended by the manufacturer. After staining, cells were fixed in 2% paraformaldehyde. TLR4 mean fluorescence intensity (MFI) was measured in the Gr-1-high gate (granulocytes), sidescatter low and F4/80 positive (monocytes), and sidescatter high and F4/80 positive (macrophages) gated populations.
###end p 52
###begin title 53
Pathology.
###end title 53
###begin p 54
###xml 974 976 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b027">27</xref>
###xml 977 979 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b028">28</xref>
Lungs and spleens for histology were harvested after infection, fixed in 10% formalin and embedded in paraffin. Sections of 4 mum were stained with hematoxylin-eosin, and analyzed by a pathologist who was blinded as to groups. To score lung inflammation and damage, the entire lung surface was analyzed with respect to the following parameters: surface with pneumonia, necrosis and/or formation of abscess, interstitial inflammation, endothelialitis, bronchitis, edema, thrombus formation, and pleuritis. Each parameter was graded on a scale of 0 to 4: 0, absent; 1, mild; 2, moderate; 3, severe; and 4, very severe. The total "lung inflammation score" was expressed as the sum of the scores for each parameter, the maximum being 32. Spleen sections were scored on inflammation, necrosis/abscess formation, and thrombus formation using the scale given above. The maximum total spleen inflammation score was 12. Granulocyte staining was done exactly as described previously [27,28].
###end p 54
###begin title 55
Statistical Analysis
###end title 55
###begin p 56
###xml 384 385 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Values are expressed as mean +/- standard error of the mean (SEM). Differences between groups were analyzed by Mann-Whitney U test or Kruskal-Wallis analysis with Dunn post hoc test where appropriate. For survival analysis, Kaplan-Meier analysis followed by log-rank test was performed. These analyses were performed using GraphPad Prism version 4.00, GraphPad Software (). Values of p < 0.05 were considered statistically significant.
###end p 56
###begin title 57
Results
###end title 57
###begin title 58
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Characteristics
###end title 58
###begin p 59
###xml 45 60 45 60 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 194 209 194 209 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 294 309 294 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 45 60 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 125 137 <span type="species:ncbi:9606">participants</span>
###xml 194 209 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 294 309 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 488 496 <span type="species:ncbi:9606">patients</span>
###xml 518 525 <span type="species:ncbi:9606">patient</span>
A total of 34 patients with sepsis caused by B. pseudomallei (mean age 52 y, range 18-86 y; 50% male) and 32 healthy control participants (mean age 41 y, range 21-59 y; 71% male) were enrolled. B. pseudomallei was cultured from body material from all patients: blood cultures were positive for B. pseudomallei in 21 patients (61.7%), throat swab or tracheal suction in 13 patients (38.0%), sputum in seven patients (21.0%), pus from abscesses in seven patients (21.0%), and urine in five patients (14.7%). The overall patient mortality was 44%.
###end p 59
###begin title 60
###xml 10 64 10 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14, LY96 (MD-2), TLR1, TLR2, TLR3, TLR4, TLR5, TLR8,</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 116 124 <span type="species:ncbi:9606">Patients</span>
Increased CD14, LY96 (MD-2), TLR1, TLR2, TLR3, TLR4, TLR5, TLR8, and TLR10 mRNA Levels in Peripheral Blood Cells of Patients with Septic Melioidosis
###end title 60
###begin p 61
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040248-t001">Table 1</xref>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 900 907 900 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040248-t001">Table 1</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 325 333 <span type="species:ncbi:9606">Patients</span>
###xml 957 965 <span type="species:ncbi:9606">patients</span>
###xml 1007 1015 <span type="species:ncbi:9606">patients</span>
To obtain a first insight into TLR gene expression during melioidosis, we quantified TLR mRNAs in blood leukocytes harvested from patients with septic melioidosis and healthy controls. MLPA was performed on RNA isolated from whole blood leukocytes as well as from monocyte- and granulocyte-enriched (> 98% pure) populations. Patients with melioidosis displayed elevated mRNA levels for most TLRs and TLR-related proteins in unfractionated leukocytes, monocytes, and granulocytes (Table 1; data of unfractionated leukocytes not shown). Specifically, melioidosis was associated with enhanced expression of monocyte and granulocyte mRNAs encoding TLR1, TLR2, TLR4 (R01 and R04), TLR5, TLR8 (R01 and R02), and the TLR4 co-receptors LY96 (previously known as MD-2) and CD14. Of note, TLR10 mRNA was up-regulated only in unfractionated leukocytes (unpublished data) and granulocytes, but not in monocytes (Table 1). The mRNAs encoding TLR3, TLR7 (both similar in patients and controls), and TLR9 (undetectable in patients and controls) were not influenced by melioidosis.
###end p 61
###begin p 62
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 85 93 <span type="species:ncbi:9606">Patients</span>
Toll-Like Receptor mRNA Expression in Peripheral Blood Monocytes and Granulocytes of Patients with Septic Melioidosis (n = 34) and Healthy Controls (n = 32)
###end p 62
###begin title 63
###xml 117 125 <span type="species:ncbi:9606">Patients</span>
Increased Expression of CD14, TLR1, TLR2, and TLR4 on the Cell Surfaces of Circulating Monocytes and Granulocytes of Patients with Septic Melioidosis
###end title 63
###begin p 64
###xml 27 42 27 42 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g001">Figure 1</xref>
###xml 668 676 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g001">Figure 1</xref>
###xml 27 42 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 458 466 <span type="species:ncbi:9606">patients</span>
To determine the effect of B. pseudomallei sepsis on TLR protein expression at the surface of peripheral blood cells, we compared the expression of CD14, TLR1, TLR2, and TLR4 on circulating monocytes and granulocytes of patients with melioidosis and healthy controls using FACS analysis. Relative to controls, patients displayed higher cell-associated levels of CD14, TLR1, TLR2, and TLR4 on both monocytes and granulocytes (Figure 1A). In addition, in five patients from whom blood could be obtained after recovery (14 d after admission), monocyte expression of CD14, TLR2, and TLR4 decreased during follow-up, whereas TLR1 levels did not change in a consistent way (Figure 1B).
###end p 64
###begin title 65
###xml 101 109 <span type="species:ncbi:9606">Patients</span>
Increased Expression of CD14, TLR1, TLR2, and TLR4 on Peripheral Blood Monocytes and Granulocytes of Patients with Melioidosis
###end title 65
###begin p 66
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
(A) Increased expression of CD14, TLR1, TLR2, and TLR4 on peripheral blood monocytes and granulocytes of patients with severe melioidosis (triangles; n = 34) and healthy controls (squares; n = 32). Horizontal lines indicate median MFI.
###end p 66
###begin p 67
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
(B). Patients (n = 5) who survived after 2 wk of intensive treatment showed normalization of CD14, TLR2, and TLR4, but not of TLR1 expression on the cell surface of monocytes at discharge.
###end p 67
###begin p 68
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
ns, not significant. *p < 0.05; **p < 0.01; ***p < 0.001.
###end p 68
###begin title 69
###xml 55 70 55 70 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 55 70 <span type="species:ncbi:28450">B. pseudomallei</span>
TLR2 and TLR4 Contribute to Cellular Responsiveness to B. pseudomallei In Vitro
###end title 69
###begin p 70
###xml 498 513 494 509 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 717 732 709 724 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 743 751 735 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g002">Figure 2</xref>
###xml 757 758 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g002">2</xref>
###xml 873 888 865 880 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 972 980 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g002">Figure 2</xref>
###xml 1068 1083 1060 1075 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 498 513 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 717 732 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 873 888 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1068 1083 <span type="species:ncbi:28450">B. pseudomallei</span>
Having established that in particular TLR2 and TLR4 become up-regulated at the surface of blood leukocytes in patients with severe melioidosis, we sought to obtain insights into the function of these TLRs in melioidosis by testing the requirement of TLR2 and TLR4 signaling upon first encounter between the bacterium and the host. We first tested the capacity of alveolar macrophages and whole blood harvested from WT, TLR2 KO, or TLR4 KO mice to release TNFalpha upon stimulation with heat-killed B. pseudomallei (effector:target ratio 1:10). Whole blood and alveolar macrophages obtained from TLR2 KO or TLR4 KO mice released less TNFalpha than did alveolar macrophages and blood from WT mice upon stimulation with B. pseudomallei in vitro (Figure 2A and 2B). Consistent with these KO data, HEK293 cells stably transfected with either CD14/TLR2 or CD14/TLR4 responded to B. pseudomallei as reflected by a 10x to 100x increase in the release of IL8 into the supernatant (Figure 2C). These data suggest that both TLR2 and TLR4 contribute to cellular responsiveness to B. pseudomallei in vitro.
###end p 70
###begin title 71
###xml 55 70 55 70 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 55 70 <span type="species:ncbi:28450">B. pseudomallei</span>
TLR2 and TLR4 Contribute to Cellular Responsiveness to B. pseudomallei In Vitro
###end title 71
###begin p 72
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 178 193 178 193 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 178 193 <span type="species:ncbi:28450">B. pseudomallei</span>
(A and B) Freshly isolated alveolar macrophages (A) and whole blood (B) of WT, TLR2 KO, and TLR4 KO mice (n = 8 per group) were incubated with RPMI 1640 (control) or heat-killed B. pseudomallei (equivalent 105 CFU; target:effector ratio 1:10) for 16 h before TNFalpha production was measured.
###end p 72
###begin p 73
###xml 114 129 114 129 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 151 166 151 166 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 114 129 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 151 166 <span type="species:ncbi:28450">B. pseudomallei</span>
(C) HEK293 cells stably transfected with CD14, CD14/TLR2, or CD14/TLR4 were incubated for 6 h with medium, LPS of B. pseudomallei 1026, or heat-killed B. pseudomallei before measurement of IL8 in the supernatant.
###end p 73
###begin p 74
###xml 23 24 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 34 35 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are mean +/- SEM (n = 4). ***p < 0.001.
###end p 74
###begin title 75
###xml 11 26 11 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 11 26 <span type="species:ncbi:28450">B. pseudomallei</span>
The LPS of B. pseudomallei Signals through TLR2
###end title 75
###begin p 76
###xml 281 296 281 296 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 444 459 444 459 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g002">Figure 2</xref>
###xml 281 296 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 444 459 <span type="species:ncbi:28450">B. pseudomallei</span>
LPS has been implicated as playing a major role in the induction of an innate immune response to gram-negative bacteria. Although TLR4 is considered the LPS receptor, LPS derived from some bacteria are recognized by TLR2. We therefore were interested to determine whether LPS from B. pseudomallei is recognized by TLR2 or TLR4. Remarkably, using HEK293 cells stably transfected with either CD14/TLR2 or CD14/TLR4, we found that purified LPS of B. pseudomallei 1026b signals through TLR2 and not through TLR4 (Figure 2C).
###end p 76
###begin title 77
###xml 55 70 55 70 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
###xml 55 70 <span type="species:ncbi:28450">B. pseudomallei</span>
TLR2 KO Mice, but Not TLR4 KO Mice, Are Protected from B. pseudomallei-Induced Death
###end title 77
###begin p 78
###xml 70 85 70 85 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 261 276 261 276 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g003">Figure 3</xref>
###xml 70 85 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 261 276 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
Having established that TLR2 and TLR4 take part in the recognition of B. pseudomallei by immune cells in vitro, we next investigated the involvement of these receptors in the outcome of melioidosis. TLR2 KO, TLR4 KO, and WT mice were intranasally infected with B. pseudomallei and followed for 6 wk. All WT and TLR4 KO mice died within 5 d after inoculation. However, mortality was delayed and reduced among TLR2 KO mice, of which 40% survived until the end of the 6 wk observation period (p < 0.0001 for the differences between both mouse strains; Figure 3).
###end p 78
###begin title 79
###xml 20 24 <span type="species:ncbi:10090">Mice</span>
###xml 45 49 <span type="species:ncbi:10090">Mice</span>
Survival of TLR2 KO Mice, but Not of TLR4 KO Mice, Is Enhanced during Experimental Melioidosis
###end title 79
###begin p 80
###xml 47 62 47 62 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 62 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
(A) Survival after intranasal inoculation with B. pseudomallei in WT (open circles), TLR2 KO mice (closed squares) and (B) TLR4 KO mice (closed squares). Mortality was assessed twice daily for 6 wk. n = 12 per group. p-Value indicates the difference between TLR2 KO and WT mice. ns, not significant.
###end p 80
###begin title 81
###xml 59 74 59 74 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
###xml 59 74 <span type="species:ncbi:28450">B. pseudomallei</span>
TLR2 KO Mice, but Not TLR4 KO Mice, Show Reduced Growth of B. pseudomallei In Vivo
###end title 81
###begin p 82
###xml 167 182 167 182 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 433 441 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g004">Figure 4</xref>
###xml 852 853 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 874 875 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1090 1105 1090 1105 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1127 1128 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1239 1254 1239 1254 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 167 182 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1090 1105 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
###xml 1239 1254 <span type="species:ncbi:28450">B. pseudomallei</span>
To obtain insight into the mechanisms underlying the reduced mortality of TLR2 KO mice during experimental melioidosis, we infected WT, TLR2 KO, and TLR4 KO mice with B. pseudomallei and sacrificed the mice after 24, 48, and 72 h (i.e., directly before the first predicted death in WT mice) to determine bacterial loads in lungs (the primary site of the infection), blood, and spleen (to evaluate extent of bacterial dissemination) (Figure 4). Relative to WT mice, TLR2 KO mice displayed strongly reduced bacterial loads in lungs, blood, and spleen at 72 h; this was also observed at the 48 h time point, although the difference did not reach statistical significance. In TLR2 KO mice that survived 6 wk after inoculation almost all bacteria were effectively cleared (unpublished data). TLR4 KO mice demonstrated higher bacterial loads only in spleen (p < 0.001) and blood (p < 0.05) at 24 h after infection; however, at later time points bacterial burdens did not differ significantly in TLR4 KO and WT mice in all body compartments except for the spleen at 72 h, revealing modestly fewer B. pseudomallei CFU in TLR4 KO mice (p < 0.001). Together, these data suggest that TLR4 may play a minor role in limiting the early dissemination of B. pseudomallei from the lungs and, more strikingly, that the presence of TLR2 facilitates the growth of this pathogen in lungs and the subsequent spread to distant body sites.
###end p 82
###begin title 83
Bacterial Loads in Lungs, Spleen, and Blood
###end title 83
###begin p 84
###xml 270 271 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 330 345 328 343 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 436 437 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 449 450 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 330 345 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
TLR2 KO mice demonstrate strongly reduced bacterial loads at 72 h after infection in lungs (A), spleen (B), and blood (C). TLR4 KO mice showed a modestly enhanced outgrowth at 24 h after infection in spleen (E) and blood (F) but not in lungs (D). Data are mean +/- SEM (n = 8 per group) at 24, 48, and 72 h after inoculation with B. pseudomallei in WT mice (open bars), TLR2 KO mice (black bars), and TLR4 KO mice (crosshatched bars). *p < 0.05; ***p < 0.0001. ns, not significant.
###end p 84
###begin title 85
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
TLR2 KO Mice Demonstrate Reduced Lung Inflammation
###end title 85
###begin p 86
###xml 114 129 114 129 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 293 308 293 308 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 594 602 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g005">Figure 5</xref>
###xml 739 747 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g005">Figure 5</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g005">5</xref>
###xml 979 987 979 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g005">Figure 5</xref>
###xml 114 129 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 293 308 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
To obtain further insight into the involvement of TLR2 and TLR4 in the inflammatory response after infection with B. pseudomallei, we semiquantitatively scored lung histology slides generated from WT, TLR2 KO, and TLR4 KO mice at various time points after infection. Infection of WT mice with B. pseudomallei was characterized by severe pulmonary inflammation, with abscess formation, necrosis, endothelialitis, and thrombus formation. Consistent with the observed reduced bacterial outgrowth, TLR2 KO mice displayed reduced organ inflammation at 72 h postinfection when compared with WT mice (Figure 5). Accordingly, the number of neutrophils present in the lung, as analyzed by Gr1-immunostaining, was lower in the TLR2 KO mice (insets, Figure 5A-5F). As expected, TLR2 KO mice that survived the 6 wk survival study described above showed decreased lung inflammation as compared to the 72 h time point; the abscesses that were still present were encapsulated in these animals (Figure 5H). In contrast with the TLR2 KO mice, the TLR4 KO mice showed similar inflammation compared with WT mice (unpublished data).
###end p 86
###begin title 87
###xml 37 41 <span type="species:ncbi:10090">Mice</span>
Reduced Lung Inflammation in TLR2 KO Mice 72 Hours after Infection
###end title 87
###begin p 88
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 170 186 170 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei.</italic>
###xml 767 782 765 780 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 835 843 833 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g003">Figure 3</xref>
###xml 1128 1129 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 170 185 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 767 782 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
Representative lung histology of WT (A, C, and E) and TLR2 KO mice (B, D, and F) at 24 h (A and B), 48 h (C and D), and 72 h (E and F) after inoculation with 5 x 102 CFU B. pseudomallei. TLR2 KO showed significantly less inflammation, pleuritis, peribronchial inflammation, edema, endothelialitis, and necrosis 72 h after infection in the mice (F and G) compared to WT (E-G). Pathology scores (mean +/- SEM) (G) were calculated as described in the Methods section; open bars represent WT mice, and solid bars represent the TLR2 KO mice. The insets (A-F) are representative images of immunostaining for granulocytes, showing dense granulocytic infiltrations and confirming reduced inflammation and granulocyte influx in the TLR2 KO mice at 72 h after inoculation with B. pseudomallei. TLR2 KO mice that survived the experiment shown in Figure 3A were examined 6 wk after inoculation; as expected, they showed decreased organ inflammation as compared to the 72 h time point The abscesses that were still present were encapsulated (H). Magnification, 20x. All data are from eight mice per group at each time point, except for (H) (n = 5).
###end p 88
###begin title 89
###xml 110 114 <span type="species:ncbi:10090">Mice</span>
Diminished Late Proinflammatory Cytokine and Increased Early Anti-inflammatory Cytokine Production in TLR2 KO Mice
###end title 89
###begin p 90
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b029">29</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b030">30</xref>
###xml 433 441 429 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g006">Figure 6</xref>
###xml 548 549 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 561 562 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 695 696 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 966 974 958 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g007">Figure 7</xref>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
The success of combating infections in the lung strongly depends on the efficacy of the local inflammatory response elicited [29,30]. In order to study the extent and kinetics of the inflammatory response, we sacrificed WT, TLR2 KO, and TLR4 KO mice at multiple time points after infection and measured the concentrations of the proinflammatory cytokines TNFalpha and IL6 and the anti-inflammatory cytokine IL10 in lung homogenates (Figure 6). TNFalpha and IL6 levels were lower in TLR2 KO mice than in WT mice, especially at 72 h after infection (p < 0.05 and p < 0.001, respectively). In addition, lung IL10 concentrations were moderately lower in TLR2 KO mice at 24 and 48 h after infection (p < 0.05). In contrast, the pulmonary levels of these mediators were similar in TLR4 KO and WT mice at all time points. In addition, TLR2 deficiency did not influence the expression of TLR4 on lung macrophages or blood monocytes or granulocytes throughout the infection (Figure 7).
###end p 90
###begin title 91
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
TLR2 KO Mice, but Not TLR4 KO Mice, Show Reduced Pulmonary Cytokine Levels during Experimental Melioidosis
###end title 91
###begin p 92
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 170 185 170 185 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 421 422 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 433 434 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 447 448 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 170 185 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
WT mice (open symbols) (A-F), TLR2 KO mice (closed symbols) (A, C, and E), and TLR4 KO mice (closed symbols) (B, D, and F) were intranasally infected with 5 x 102 CFU of B. pseudomallei. 24, 48, and 72 h after inoculation mice were sacrificed, lungs were removed, and TNFalpha (A and B), IL6 (C and D), and IL10 (E and F) were measured in lung homogenates. Data are means +/- SEM of eight mice per group per time point. *p < 0.05; **p < 0.001; ***p < 0.0001.
###end p 92
###begin title 93
###xml 91 106 91 106 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 44 48 <span type="species:ncbi:10090">Mice</span>
###xml 64 68 <span type="species:ncbi:10090">Mice</span>
###xml 91 106 <span type="species:ncbi:28450">B. pseudomallei</span>
No Difference in TLR4 Expression in TLR2 KO Mice Compared to WT Mice during Infection with B. pseudomallei
###end title 93
###begin p 94
###xml 106 121 106 121 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 241 242 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 106 121 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
TLR4 cell surface expression is depicted over time (0, 24, 48, and 72 h after intranasal inoculation with B. pseudomallei), on the lung macrophages (A), blood monocytes (B), and blood granulocytes (C). Data are expressed as mean +/- SEM and n = 4 mice per group at each time point. MFI, mean fluorescence intensity.
###end p 94
###begin title 95
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
TLR2 KO Mice, but Not TLR4 KO Mice, Demonstrate Decreased Distant Organ Injury
###end title 95
###begin p 96
###xml 105 120 105 120 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 473 481 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g008">Figure 8</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g008">8</xref>
###xml 683 691 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g008">Figure 8</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g008">8</xref>
###xml 105 120 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
To further evaluate the role of TLR2 and TLR4 in the systemic inflammatory response after infection with B. pseudomallei, we semiquantitatively scored spleen histology slides generated from infected mice and performed routine clinical chemistry to evaluate hepatic and renal injury. No differences were observed between WT and TLR4 KO mice at any time point (unpublished data). However, TLR2 KO showed diminished inflammation in their spleens when compared to the WT mice (Figure 8A-8C). Furthermore, liver and kidney function were relatively well preserved in TLR2 KO mice, as reflected by lower ASAT, ALAT, blood urea nitrogen (BUN), and creatinine plasma levels in these animals (Figure 8D-8G).
###end p 96
###begin title 97
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
TLR2 KO Mice Demonstrate Reduced Distant Organ Injury
###end title 97
###begin p 98
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 54 69 54 69 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 832 833 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 844 845 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 54 69 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
Mice were intranasally inoculated with 5 x 102 CFU of B. pseudomallei. After 72 h, representative spleen histology of WT (A) and TLR2 KO (B) mice demonstrated decreased inflammation and less thrombus formation in the TLR2 KO spleens. Magnification, 12.5x. Arrows indicate increased thrombus formation in the WT mice compared to TLR2 KO mice. The reduced inflammation and injury in the spleen at 72 h after infection (C) was confirmed by the semiquantitative pathology score described in the Methods. At this time point TLR2 KO mice also showed less hepatic injury, as reflected by the plasma concentrations of ASAT (D) and ALAT (E), and less renal failure, as reflected by plasma creatinine (F) and blood urea nitrogen (BUN) (G). Data are expressed as mean +/- SEM of eight WT mice (open bars) and eight TLR2 KO mice (black bars). *p < 0.05; **p < 0.01 versus WT control.
###end p 98
###begin title 99
Discussion
###end title 99
###begin p 100
###xml 610 622 610 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 843 858 839 854 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 875 890 871 886 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 270 278 <span type="species:ncbi:9606">Patients</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 843 858 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 875 890 <span type="species:ncbi:28450">B. pseudomallei</span>
In the present study we aimed to characterize the expression and function of the TLRs in septic melioidosis, linking observational studies in patients with culture-proven disease with functional studies in TLR-deficient mice. We made the following key observations. (1) Patients with septic melioidosis have increased expression of CD14, TLR1, TLR2, and TLR4 on the cell surfaces of circulating monocytes and granulocytes and increased levels of mRNAs encoding CD14, LY96, TLR1, TLR2, TLR3, TLR4, TLR5, TLR8, and TLR10 in peripheral blood cells. (2) Both TLR2 and TLR4 contribute to cellular responsiveness to Burkholderia in vitro, as reflected by reduced TNFalpha release by alveolar macrophages and whole blood from TLR2 KO and TLR4 KO mice and by activation of HEK293 cells stably transfected with either TLR2 or TLR4 upon incubation with B. pseudomallei. (3) The LPS of B. pseudomallei signals through TLR2 and not through TLR4. And (4) TLR4 is not important for protective immunity against experimentally induced melioidosis, whereas TLR2 is associated with the growth and dissemination of the infection, significantly contributing to distant organ injury and lethality.
###end p 100
###begin p 101
###xml 289 304 289 304 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b015">15</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b031">31</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b032">32</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b034">34</xref>
###xml 1193 1197 1193 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1690 1692 1690 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b035">35</xref>
###xml 1693 1695 1693 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b036">36</xref>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 289 304 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 654 660 <span type="species:ncbi:9606">humans</span>
###xml 973 981 <span type="species:ncbi:9606">patients</span>
###xml 1680 1688 <span type="species:ncbi:9606">patients</span>
Our study is, to our knowledge, the first to provide insights into the relative gene expression of all TLR family members in peripheral blood monocytes and granulocytes in patients with severe sepsis. In blood samples obtained from 34 prospectively enrolled patients with sepsis caused by B. pseudomallei, we showed that a whole repertoire of TLRs is up-regulated at the mRNA level in both monocytes and granulocytes. Of note, patients showed enhanced monocyte and granulocyte expression of three of four TLR4 splice variants. TLR4 variant R02 remained undetectable, which is consistent with our earlier study examining alveolar macrophages from healthy humans challenged with LPS via the airways [15]. TLR4 variant R01 is involved in LPS binding and triggering of intracellular signal transduction cascades, while variants R03 and R04 lack residues 24-34, which are essential for LY96 (MD2) binding and LPS signaling [31]. The expression of TLR3 mRNA was very low in both patients and healthy controls, which can be explained by the fact that this intracellular receptor is primarily expressed by dendritic cells and to a lesser extent B and T cells [32-34]. In addition, we could not detect TLR9 mRNA in monocytes or granulocytes, which is in line with studies showing that TLR9 mRNA in particular is expressed in plasmacytoid dendritic cells and B cells. The increase in mRNAs encoding CD14, TLR1, TLR2, and TLR4 was accompanied by enhanced surface expression of the respective proteins circulating neutrophils and granulocytes. This is in accordance with two earlier clinical reports, which found increased expression of TLR2 and TLR4 on neutrophils and monocytes from septic patients [35,36].
###end p 101
###begin p 102
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b003">3</xref>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b004">4</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b005">5</xref>
###xml 245 260 245 260 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1006 1007 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b001">1</xref>
###xml 1008 1009 1008 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b002">2</xref>
###xml 1133 1149 1133 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei,</italic>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b037">37</xref>
###xml 0 6 <span type="species:ncbi:9606">Humans</span>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 245 260 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 1133 1148 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1338 1343 <span type="species:ncbi:10090">mouse</span>
Humans usually acquire melioidosis by inoculation through skin abrasions or inhalation [3,4]. Pneumonia with bacterial dissemination to distant body sites is a common presentation of melioidosis [5]. We decided to develop a mouse model in which B. pseudomallei was administered via the airways, since this route may be more clinically relevant than the intraperitoneal route used in several previous studies. We reproduced the major clinical characteristics of melioidosis, with rapid spread of bacteria to distant organs, multiple organ failure and abscess formation. Among the TLRs with enhanced expression in patients with melioidosis, we considered TLR2 and TLR4 most interesting with respect to the impact of their loss of function in experimentally induced melioidosis in mice. Indeed, of the other TLRs that showed increased expression, TLR1 has been implicated as a co-receptor together with TLR2 in the recognition of bacterial triacyl lipopeptides, whereas TLR8 senses single-stranded viral RNA [1,2]. In addition, although TLR5, as the receptor that recognizes flagellin, in theory may be involved in host defense against B. pseudomallei, a recent report suggests that TLR5 especially or exclusively senses pathogenic flagellated bacteria present in the intestinal lumen, whereas the expression of this receptor was low in the mouse lung [37].
###end p 102
###begin p 103
###xml 115 130 115 130 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040248-g002">Figure 2</xref>
###xml 325 340 325 340 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b009">9</xref>
###xml 694 716 694 716 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Salmonella typhimurium</named-content>
###xml 721 737 721 737 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 776 822 776 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae, Klebsiella pneumoniae,</italic>
###xml 827 850 827 850 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Acinetobacter baumannii</named-content>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b027">27</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b038">38</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b041">41</xref>
###xml 872 887 872 887 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 966 981 966 981 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b004">4</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b042">42</xref>
###xml 1155 1170 1155 1170 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1180 1187 1180 1187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b043">43</xref>
###xml 1350 1372 1350 1372 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Legionella pneumophila</named-content>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b044">44</xref>
###xml 1428 1443 1428 1443 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1528 1530 1528 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b045">45</xref>
###xml 1666 1676 1666 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Legionella</italic>
###xml 1680 1692 1680 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 1800 1822 1800 1822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 1970 1972 1970 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b046">46</xref>
###xml 115 130 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 325 340 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 694 716 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 721 737 <span type="species:ncbi:562">Escherichia coli</span>
###xml 776 798 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 800 821 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 827 850 <span type="species:ncbi:470">Acinetobacter baumannii</span>
###xml 872 887 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 966 981 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1105 1110 <span type="species:ncbi:10090">mouse</span>
###xml 1155 1170 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1180 1187 <span type="species:ncbi:562">E. coli</span>
###xml 1350 1372 <span type="species:ncbi:446">Legionella pneumophila</span>
###xml 1428 1443 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1800 1822 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
A remarkable and unexpected finding was that, although TLR4 appeared very important for cellular responsiveness to B. pseudomallei in vitro (Figure 2), this receptor does not significantly contribute to host defense against melioidosis in vivo. In line with these in vivo observations, we demonstrated that purified LPS from B. pseudomallei 1026b (the strain also used in the in vivo infection studies) activates HEK293 cells via TLR2, not via TLR4. The evidence that TLR4 has an important role in gram-negative infections is exclusively derived from models using bacteria that express LPS recognized by TLR4 [9]. Indeed, TLR4-deficient mice are more susceptible to gram-negative sepsis due to Salmonella typhimurium and Escherichia coli and to gram-negative pneumonia due to Haemophilus influenzae, Klebsiella pneumoniae, and Acinetobacter baumannii [27,38-41]. Of note, B. pseudomallei LPS differs in several aspects from the LPS of other gram-negative organisms: B. pseudomallei LPS exhibits weaker pyrogenic activity in rodents compared with enterobacterial LPS [4,42], and LPS-mediated activation of mouse macrophages in vitro is slower for LPS from B. pseudomallei than for E. coli LPS [43]. In this respect it is of interest that our laboratory previously established that TLR4 is not involved in host defense against pulmonary infection with Legionella pneumophila [44], a gram-negative bacterium of which the LPS, like B. pseudomallei LPS, is a weak inducer of proinflammatory cytokine production by mononuclear cells [45]. Hence, it is conceivable that absent or insufficient LPS sensing by TLR4 makes this receptor redundant during infection in vivo with Legionella or Burkholderia. In addition, the recent finding that TLR4 does not mediate resistance against acute lung infection due to Pseudomonas aeruginosa suggests that for some gram-negative pathogens signaling to other pattern recognition receptors may compensate for the loss of LPS-TLR4 signaling [46].
###end p 103
###begin p 104
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycoplasma</italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b001">1</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b002">2</xref>
###xml 622 633 622 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Neisseria)</italic>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b001">1</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b002">2</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b047">47</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b049">49</xref>
###xml 791 806 791 806 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 918 930 914 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 1064 1079 1060 1075 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1115 1130 1111 1126 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 1247 1259 1243 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia</italic>
###xml 1649 1672 1645 1668 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Yersinia enterocolitica</named-content>
###xml 1676 1692 1672 1688 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Candida albicans</named-content>
###xml 1856 1858 1852 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b050">50</xref>
###xml 1859 1861 1855 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b051">51</xref>
###xml 1879 1886 1875 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
###xml 2044 2046 2040 2042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b051">51</xref>
###xml 2106 2108 2102 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b052">52</xref>
###xml 2109 2111 2105 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b053">53</xref>
###xml 2222 2237 2218 2233 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 2850 2865 2842 2857 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 319 332 <span type="species:ncbi:11234">measles virus</span>
###xml 791 806 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1064 1079 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1115 1130 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 1378 1382 <span type="species:ncbi:10090">mice</span>
###xml 1584 1588 <span type="species:ncbi:10090">mice</span>
###xml 1649 1672 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 1676 1692 <span type="species:ncbi:5476">Candida albicans</span>
###xml 2163 2167 <span type="species:ncbi:10090">mice</span>
###xml 2222 2237 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 2318 2322 <span type="species:ncbi:10090">mice</span>
###xml 2850 2865 <span type="species:ncbi:28450">B. pseudomallei</span>
TLR2 is a promiscuous pattern recognition receptor recognizing multiple ligands expressed by a variety of microorganisms such as Mycoplasma (diacyl lipopeptides), mycobacteria (triacyl lipopeptides, lipoarabinomannan), fungi (zymosan, phospholipomannan), parasites (tGPI-mutin), and viruses (hemagglutinin protein from measles virus and unidentified structures of herpes simplex virus) [1,2]. In addition, TLR2 can signal a number of PAMPs expressed by bacteria, in particular lipoteichoic acid (exclusively expressed by gram-positive bacteria), peptidoglycan and triacyl lipopeptides (found in most bacteria), and porins (Neisseria) [1,2]. Finally, TLR2 may be activated by LPS from some gram-negative bacteria [47-49]. We here found that TLR2 contributes to the responsiveness of cells to B. pseudomallei using two complementary approaches: TLR2 KO macrophages and blood produced less TNFalpha upon stimulation with Burkholderia, whereas TLR2 transfected HEK293 cells released large amounts of IL8 upon incubation with this bacterium. In addition, we identified B. pseudomallei LPS as a TLR2 ligand. Conceivably, B. pseudomallei expresses more TLR2 ligands, with peptidoglycan and lipopeptides being possible candidates. The interaction between Burkholderia and TLR2 clearly impairs the protective immune response against this bacterium, as reflected by the fact that TLR2 KO mice displayed a strongly reduced mortality during experimental melioidosis, which was associated with a diminished bacterial growth and dissemination, and reduced distant organ injury. Previously, TLR2 KO mice were found to be less susceptible to lethal infections with Yersinia enterocolitica or Candida albicans through a mechanism that likely involved a stronger type 1 cytokine response due to diminished production of the prototypic type 2 cytokine IL10 during infection [50,51]. In the case of Candida infection, TLR2 induced proliferation and survival of regulatory T cells, which appeared largely responsible for the increased IL10 release induced by TLR2 [51]. Although a type 1 response is protective in melioidosis [52,53], a loss of type 2 cytokine stimulation in TLR2 KO mice cannot explain the protection of these animals during B. pseudomallei infection. First, the differences in IL10 concentrations between TLR2 KO and WT mice were minor and much less profound than the concurrent differences in the proinflammatory cytokine TNFalpha. Second, the concentrations of the prototypic type 1 cytokine interferon gamma remained very low or undetectable throughout the entire observation period (unpublished data). Finally, antibody-mediated depletion of regulatory T cells did not influence the outcome of melioidosis in our model (unpublished data). More studies are warranted to dissect the exact mechanism by which TLR2 facilitates the growth and spread of B. pseudomallei in vivo.
###end p 104
###begin p 105
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b003">3</xref>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040248-b004">4</xref>
###xml 335 350 335 350 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 385 400 385 400 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 743 758 743 758 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 335 350 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 385 400 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 743 758 <span type="species:ncbi:28450">B. pseudomallei</span>
Melioidosis is a debilitating disease with an unacceptably high mortality rate [3,4]. We here demonstrate that the expression of multiple TLRs is up-regulated in peripheral blood leukocytes in septic patients with melioidosis. Most remarkable, although our results show that both TLR2 and TLR4 contribute to cellular responsiveness to B. pseudomallei in vitro, TLR2 detects the LPS of B. pseudomallei and only TLR2 impacts on the immune response of the intact host in vivo. Of note, TLR4 does not contribute to protective immunity in this severe gram-negative infection. Taken together, these findings suggest that septic melioidosis can be seen as the clinical manifestation of a TLR-mediated dysregulation of the immune response to invasive B. pseudomallei. In addition, this report further undermines the paradigm regarding TLR4 as "the gram-negative receptor" and TLR2 as "the gram-positive receptor." Inhibition of TLR2 may be a useful adjunctive therapy for melioidosis.
###end p 105
###begin title 106
Supporting Information
###end title 106
###begin title 107
Translation of the abstract into Thai by Direk Limmathurotsakul
###end title 107
###begin p 108
(74 KB PDF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 356 363 <span type="species:ncbi:171585">Peacock</span>
We are grateful to the staff of Sappasitiprasong Hospital, especially Professor Wipada Chaowagul. In addition, we thank Anita de Boer, Marieke ten Brink, and Joost Daalhuisen for expert technical assistance. We thank Dr. Douglas Golenbock and Dr. Shizuo Akira for generously providing us with transfected HEK293 cells and TLR KO mice, respectively. Sharon Peacock is a Wellcome Trust Career Development Fellow.
###end p 110
###begin title 111
Abbreviations
###end title 111
###begin p 112
alanine aminotransferase
###end p 112
###begin p 113
aspartate aminotransferase
###end p 113
###begin p 114
colony-forming unit(s)
###end p 114
###begin p 115
interleukin
###end p 115
###begin p 116
knockout
###end p 116
###begin p 117
lipopolysaccharide
###end p 117
###begin p 118
mean fluorescence intensity
###end p 118
###begin p 119
multiplex ligation-dependent probe amplification
###end p 119
###begin p 120
pathogen-associated molecular pattern
###end p 120
###begin p 121
standard error of the mean
###end p 121
###begin p 122
Toll-like receptor
###end p 122
###begin p 123
tumor necrosis factor alpha
###end p 123
###begin p 124
wild type
###end p 124
###begin title 125
References
###end title 125
###begin article-title 126
Pathogen recognition and innate immunity
###end article-title 126
###begin article-title 127
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large
###end article-title 127
###begin article-title 128
Melioidosis: Epidemiology, pathophysiology, and management
###end article-title 128
###begin article-title 129
###xml 48 73 48 73 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 48 73 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Melioidosis: Insights into the pathogenicity of Burkholderia pseudomallei
###end article-title 129
###begin article-title 130
Melioidosis: An important cause of pneumonia in residents of and travellers returned from endemic regions
###end article-title 130
###begin article-title 131
Melioidosis
###end article-title 131
###begin article-title 132
Melioidosis in northern Australia, 2001-02
###end article-title 132
###begin article-title 133
Melioidosis: The tip of the iceberg?
###end article-title 133
###begin article-title 134
Innate immune sensing and its roots: The story of endotoxin
###end article-title 134
###begin article-title 135
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
###end article-title 135
###begin article-title 136
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
###end article-title 136
###begin article-title 137
###xml 114 120 <span type="species:ncbi:9606">humans</span>
Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo
###end article-title 137
###begin article-title 138
High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells
###end article-title 138
###begin article-title 139
Anti-inflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers
###end article-title 139
###begin article-title 140
Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin
###end article-title 140
###begin article-title 141
###xml 80 101 80 101 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 80 101 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
###end article-title 141
###begin article-title 142
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lps</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
###end article-title 142
###begin article-title 143
###xml 72 78 <span type="species:ncbi:10090">murine</span>
Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense
###end article-title 143
###begin article-title 144
###xml 115 137 <span type="species:ncbi:727">haemophilus influenzae</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung
###end article-title 144
###begin article-title 145
###xml 21 46 21 46 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 102 121 102 121 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia mallei</named-content>
###xml 143 158 143 158 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 21 46 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 102 121 <span type="species:ncbi:13373">Burkholderia mallei</span>
###xml 143 158 <span type="species:ncbi:28450">B. pseudomallei</span>
Genomic diversity of Burkholderia pseudomallei clinical isolates: Subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b
###end article-title 145
###begin article-title 146
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Biodefense-driven murine model of pneumonic melioidosis
###end article-title 146
###begin article-title 147
###xml 114 139 114 139 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 114 139 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Detection of bacterial virulence genes by subtractive hybridization: Identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant
###end article-title 147
###begin article-title 148
###xml 0 19 0 19 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia mallei</named-content>
###xml 0 19 <span type="species:ncbi:13373">Burkholderia mallei</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes
###end article-title 148
###begin article-title 149
###xml 39 64 39 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 39 64 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins
###end article-title 149
###begin article-title 150
Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction
###end article-title 150
###begin article-title 151
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
###end article-title 151
###begin article-title 152
###xml 69 92 69 92 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Acinetobacter pneumonia</named-content>
###xml 62 68 <span type="species:ncbi:10090">murine</span>
Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia
###end article-title 152
###begin article-title 153
Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia
###end article-title 153
###begin article-title 154
Cytokines in innate host defense in the lung
###end article-title 154
###begin article-title 155
Pneumonia models and innate immunity to respiratory bacterial pathogens
###end article-title 155
###begin article-title 156
The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2
###end article-title 156
###begin article-title 157
###xml 71 76 <span type="species:ncbi:9606">human</span>
Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
###end article-title 157
###begin article-title 158
###xml 21 26 <span type="species:ncbi:9606">human</span>
Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines
###end article-title 158
###begin article-title 159
###xml 79 84 <span type="species:ncbi:9606">human</span>
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
###end article-title 159
###begin article-title 160
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Increased expression of Toll-like receptor-2 and -4 on leukocytes from patients with sepsis
###end article-title 160
###begin article-title 161
###xml 80 85 <span type="species:ncbi:9606">human</span>
Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis
###end article-title 161
###begin article-title 162
Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells
###end article-title 162
###begin article-title 163
###xml 70 80 70 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 24 30 <span type="species:ncbi:10090">murine</span>
LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection
###end article-title 163
###begin article-title 164
###xml 108 124 108 124 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
###xml 108 124 <span type="species:ncbi:562">Escherichia coli</span>
Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis
###end article-title 164
###begin article-title 165
###xml 57 79 57 79 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Haemophilus influenzae</named-content>
###xml 57 79 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung
###end article-title 165
###begin article-title 166
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice
###end article-title 166
###begin article-title 167
###xml 47 86 47 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia (Pseudomonas) pseudomallei</italic>
Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei
###end article-title 167
###begin article-title 168
###xml 131 156 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin
###end article-title 168
###begin article-title 169
###xml 71 93 71 93 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Legionella pneumophila</named-content>
###xml 71 93 <span type="species:ncbi:446">Legionella pneumophila</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model
###end article-title 169
###begin article-title 170
###xml 27 49 27 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Legionella pneumophila</named-content>
###xml 27 49 <span type="species:ncbi:446">Legionella pneumophila</span>
Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14
###end article-title 170
###begin article-title 171
###xml 62 84 62 84 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Pseudomonas aeruginosa</named-content>
###xml 62 84 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections
###end article-title 171
###begin article-title 172
Leptospiral lipopolysaccharide activates cell through a TLR2-dependent mechanism
###end article-title 172
###begin article-title 173
###xml 23 66 23 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides fragilis, Chlamydia trachomatis</italic>
###xml 71 93 71 93 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Pseudomonas aeruginosa</named-content>
###xml 23 43 <span type="species:ncbi:817">Bacteroides fragilis</span>
###xml 45 66 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 71 93 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2
###end article-title 173
###begin article-title 174
###xml 0 24 <span type="species:ncbi:837">Porphyromonas gingivalis</span>
Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4
###end article-title 174
###begin article-title 175
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia</italic>
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression
###end article-title 175
###begin article-title 176
###xml 49 65 49 65 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Candida albicans</named-content>
###xml 49 65 <span type="species:ncbi:5476">Candida albicans</span>
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells
###end article-title 176
###begin article-title 177
###xml 90 115 90 115 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 59 65 <span type="species:ncbi:10090">murine</span>
###xml 90 115 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei
###end article-title 177
###begin article-title 178
###xml 63 88 63 88 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Burkholderia pseudomallei</named-content>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 63 88 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection
###end article-title 178
###begin p 179
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 523 538 523 538 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. pseudomallei</named-content>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
###xml 523 538 <span type="species:ncbi:28450">B. pseudomallei</span>
Author contributions. WJW, CWW, NC, ACC, WC, AFdV, AMD, NPD, SJP, and TvdP designed the study. WJW, MCD, ML, and SF analysed the data. WJW, ACC, DL, and SJP enrolled patients. WJW, NC, ACC, DL, WC, AFdV, NW, AMD, NPD, SJP, and TvdP contributed to writing the paper. CWW and NC collected data or performed experiments for this study. MCD performed the MLPA technique and data analysis as mentioned in section "RNA analysis using multiplex ligation-dependent probe amplification." DL recruited patients with sepsis caused by B. pseudomallei at Sapprasithiprasong Hospital, Ubon Radchathnai, northeastern Thailand, and collected the clinical data and blood specimens for the study. ML performed some of the ex vivo and in vitro experiments. NW helped organize the clinical study.
###end p 179
###begin p 180
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: We acknowledge the support of the Dutch Foundation for Tropical Research (WOTRO) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 180
###begin p 181
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 181

